Evidence map›Paper›PMID 29123380›Full record

ArticleDrug design, development and therapy2017

Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.

Rai Muhammad Sarfraz, Mahmood Ahmad, Asif Mahmood, Muhammad Rouf Akram, Asad Abrar

Open access · goldAbstract readComparative Study
In one paragraph

Article in Drug design, development and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Directly compressed rosuvastatin calcium tablets that offer hydrotropic and micellar solubilization for improved dissolution rate and extent of drug release.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rai Muhammad SarfrazFaculty of Pharmacy, University of Sargodha, Sargodha.
Mahmood AhmadFaculty of Pharmacy and Alternative Medicines, The Islamia University of Bahawalpur, Bahawalpur.
Asif MahmoodInstitute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Muhammad Rouf AkramFaculty of Pharmacy, University of Sargodha, Sargodha.
Asad AbrarFaculty of Pharmacy and Alternative Medicines, The Islamia University of Bahawalpur, Bahawalpur.
Islamia University of Bahawalpur · PKUniversity of Sargodha · PKUniversity of Agriculture Faisalabad · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to enhance the solubility of rosuvastatin (RST) calcium by developing β-cyclodextrin-

Indexed as

Animalsbeta-CyclodextrinsCalorimetry, Differential ScanningDrug CarriersFree RadicalsHydrogelsHydrogen-Ion ConcentrationHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMicroscopy, Electron, ScanningMicrospheresParticle SizePolymerizationPolymersRabbitsRosuvastatin Calciumbeta-CyclodextrinsDrug CarriersFree RadicalsHydrogelsHydroxymethylglutaryl-CoA Reductase Inhibitorspoly(2-acrylamido-2-methyl-1-propanesulfonic acid)PolymersRosuvastatin CalciumSulfonic Acidshydrogel microparticlespolymerizationrosuvastatin calciumβ-cyclodextrin solubility

Identifiers

PMID29123380
PMCPMC5661467
OpenAlexW2766333592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.